FDA Master Protocol In Metastatic Breast Cancer Likely In The Works
This article was originally published in The Pink Sheet Daily
Executive Summary
Oct. 21 public workshop cosponsored by prominent oncology groups will discuss international genomically driven trial to test multiple agents in metastatic breast cancer.